Cassava Sciences Inc. (NASDAQ:SAVA) traded at $36.44 at close of the session on Monday, 01/23/23, made an upward move of 4.59% on its previous day’s price.
Looking at the stock we see that its previous close was $34.84 and the beta (5Y monthly) reads 0.22 with the day’s price range being $34.50 – $38.53. In terms of its 52-week price range, SAVA has a high of $62.49 and a low of $13.84. The company’s stock has lost about -3.42% over that past 30 days.
Cassava Sciences Inc. has a market cap of $1.44 billion and is expected to release its quarterly earnings report on Feb 27, 2023 – Mar 03, 2023. Estimates by analysts give the company expected earnings per share (EPS) of -$0.48, with the EPS growth for the year raised at -$1.94 for 2022 and -$1.51 for next year. These figures represent -136.60% and 22.20% growth in EPS for the two years respectively.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the SAVA stock, short term indicators assign the stock an average of Hold, while medium term indicators assign it an average of 50% Buy. Long term indicators on average place the stock in the category of 100% Buy.
Based on estimates by 3 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 1 have rated the Cassava Sciences Inc. (SAVA) stock as a Hold, while 2 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Overweight and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 15.22% off its SMA20 and 5.21% from its 50-day simple moving average. The RSI (14) is pointing at 57.86 while the volatility over the past week is 7.81% and jumps to 10.14% over the past one month. The beta value is -0.02, while the average true range (ATR) is currently pointing at 2.97. The average price target for the stock over the next 12 months is $89.33, with the estimates having a low of $44.00 and a high of $124.00. These price ends are -20.75% and -240.29% off the current price level respectively, although investors could be excited at the prospect of a -174.42% if the SAVA share price touches on the median price of $100.00.
Coming back to Cassava Sciences Inc. (NASDAQ:SAVA), we note that the average 3-month trading volume was 1.25 million, while that of the preceding 10-day period stands at 1.28 million. Current shares outstanding are 40.05 million.
The insiders hold 2.70% of the company’s shares while institutions hold 25.50%. The data shows that short shares as of Oct 13, 2022, stood at 9.63 million at a short ratio of 2.28. This represents a 24.03% short interest in shares outstanding on Oct 13, 2022. Shares short fall in October from the previous month at 12.55 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 23.36% up in year-to-date price movement.